⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LBRX News
LB Pharmaceuticals Inc Common Stock
Form 8-K
sec.gov
LBRX
LB Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
LBRX
Form 8-K
sec.gov
LBRX
LB Pharmaceuticals Announces $150 Million Private Placement
globenewswire.com
LBRX
Form 8-K
sec.gov
LBRX
LB Pharmaceuticals Announces Accelerated Timing of Topline Results from the Phase 3 NOVA-2 Trial of LB-102 in Schizophrenia
globenewswire.com
LBRX
LB Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
LBRX
LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations
globenewswire.com
LBRX
Form 8-K
sec.gov
LBRX
Form 8-K
sec.gov
LBRX